Individualized lesion-symptom mapping using explainable artificial intelligence for the cognitive impact of white
Ryanne Offenberg1, Alberto De Luca1, Geert Jan Biessels2
1Image Sciences Institute, UMC Utrecht, Utrecht, the Netherlands.
Neuroimage. Clinical
|April 23, 2025
Summary
We developed a new method using artificial intelligence to map how brain lesions affect cognition individually. This approach, combining convolutional neural networks (CNNs) and explainable AI (XAI), identifies specific lesion patterns linked to cognitive changes.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Cognitive Neuroscience
Background:
- Cerebral small vessel disease (CSVD) causes lesions impacting cognition.
- Current lesion-symptom mapping (LSM) methods, like support vector regression (SVR), primarily offer group-level insights.
- There is a need for individual-level LSM to understand lesion-cognition relationships.
Purpose of the Study:
- To introduce a novel, individual-level LSM approach using CNNs and XAI.
- To map the relationship between vascular lesions and cognitive impairment on a patient-specific basis.
- To evaluate the performance of the proposed method against existing techniques.
Main Methods:
- A CNN was employed to predict cognitive scores from lesion data.
- Explainable AI (XAI) techniques were integrated with the CNN to generate lesion attribution maps.
- The method was validated using simulated cognitive data and real white matter hyperintensity (WMH) maps from 821 patients, benchmarked against SVR and a fully connected neural network (FNN).
Main Results:
- The CNN demonstrated high predictive performance on simulated data (R² = 0.964).
- CNN with XAI successfully generated patient-specific attribution maps, accurately highlighting critical lesion locations.
- On real patient data, SVR showed higher predictive performance (R² = 0.291) than the CNN (R² = 0.216), though both outperformed total WMH volume (R² = 0.013).
Conclusions:
- CNNs combined with XAI offer a viable method for individual-level lesion-symptom mapping.
- The approach generates patient-specific attribution maps, providing valuable insights into lesion-cognition relationships.
- Further development of this AI-driven LSM technique holds promise for clinical applications.
Keywords:
Explainable artificial intelligenceLesion-symptom mappingMachine learningNeural networkVascular cognitive impairmentMore Related Videos
Related Concept Videos
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Prosopagnosia
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...


